Clinical trials recruiting in Loudi, China

Phase breakdown

Conditions recruiting in Loudi, China

Recruiting trials in Loudi, China

• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
  NCT07662044 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
  NCT06883305 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
  NCT04974138 · Phase: Phase 4 · Ages: 45 Years to 74 Years · Sex: All (male and female)
• China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
  NCT04974151 · Phase: Phase 4 · Ages: 45 Years to 74 Years · Sex: All (male and female)
• Phase II Study of RC1416 Injection in COPD
  NCT07402551 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female)
• TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
  NCT06829784 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Loudi, China?

6 recruiting trials have at least one study site in Loudi, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.